Document is current
Any future updates will be listed below
-
Authors
Chase, Dana M.
Shukla, Soham
Moore, Julia
Boyle, Tirza Areli Calderón
Lim, Jonathan
Perhanidis, Jessica
Hurteau, Jean A.
Schilder, Jeanne M.
-
Funding
Funding for this research was provided by:
GSK
- License Information
-
More Information
Article History
Received: 23 May 2024
Accepted: 16 July 2024
First Online: 4 August 2024
Declarations
:
: Dana Chase reports consultant fees from AstraZeneca and GSK and honoraria from AstraZeneca, GSK, Immunogen, and Seagen/Genmab. Soham Shukla, Julia Moore, Tirza Areli Calderón Boyle, Jonathan Lim, Jean A. Hurteau, and Jeanne M. Schilder are employees of GSK and may hold stock/shares in GSK. Jessica Perhanidis is an employee of GSK and reports stock/shareholder at GSK and Boston Scientific.
: Permission for authors to access/use the database was provided by Flatiron Health, Inc. This study complied with all applicable patient privacy laws. There was no direct patient contact or primary collection of individual human subject data. The data were de-identified and subject to obligations to prevent re-identification and protect patient confidentiality. Therefore, informed consent and ethics committee or institutional review board approval were not required.
